冷冻保存同种移植物用于主动脉瓣置换的长期结局
研究纳入1993年1月至2010年8月210例接受冷冻保存主动脉同种移植物置换的患者,采用无支架冠状动脉下植入技术(55例)或带冠状动脉再植的根部替换(155例),随访至2016年4月。总体死亡80例(38.1%),心脏死亡64例(30.5%),再手术69例(32.8%),结构性瓣膜退化(SVD)需再手术57例(27.1%)。结论认为冷冻保存同种移植物是有效选择,尤其适用于复杂感染性心内膜炎和育龄女性。
要点
- 总体死亡80例(38.1%),心脏死亡64例(30.5%),再手术69例(32.8%)。
- SVD需再手术57例(27.1%),无早期心内膜炎,晚期心内膜炎4例。
- 无支架技术似乎与更好的左心室重构相关,较小同种移植物尺寸是再手术的独立预测因素。
核心结论
- 冷冻保存同种移植物是有效选择,尤其适用于复杂感染性心内膜炎和育龄女性。
- 仔细选择同种移植物尺寸和植入技术可降低SVD风险。
研究设计与样本
- 回顾性研究,1993年1月至2010年8月共210例患者接受主动脉同种移植物置换,其中无支架冠状动脉下植入技术55例,带冠状动脉再植的根部替换155例,临床和超声心动图随访更新至2016年4月。
主要发现
- 总体死亡80例(38.1%),心脏死亡64例(30.5%)。
- 再手术69例(32.8%),其中SVD需再手术57例(27.1%)。
- 无早期心内膜炎发生,晚期心内膜炎4例。
- 无支架技术似乎与更好的左心室重构相关。
- 较小同种移植物尺寸是再手术的独立预测因素,与所采用的手术技术无关。
临床怎么用
- 冷冻保存同种移植物是有效选择,尤其适用于复杂感染性心内膜炎和育龄女性。
- 仔细选择同种移植物尺寸和植入技术可降低SVD风险。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: The most efficient surgical approach to severe aortic valve disease in the young adult is still debated: cryopreserved aortic allograft offers excellent hemodynamic and avoid anticoagulation, but long-term durability is influenced by structural valve deterioration (SVD). This study aimed to describe long-term results of aortic allografts and to identify factors influencing long-term durability. METHODS: From January 1993 to August 2010, 210 patients underwent aortic allograft replacement via the free-hand subcoronary implantation technique (N = 55) or root replacement with coronary reimplantation (N = 155). Clinic and echocardiographic follow-up was updated to April 2016. RESULTS: Overall mortality and cardiac mortality occurred in 80 (38.1%) and 64 (30.5%) patients, respectively. Reoperation was required in 69 cases (32.8%), whereas SVD required reoperation in 57 cases (27.1%). No early endocarditis occurred, whereas late endocarditis occurred in 4 patients. The free-hand technique seems to be associated with improved left ventricular remodeling compared with the root-replacement technique, and smaller allograft size represents a predictor of reoperation independently on the surgical technique used. In the overall population, there were 44 women of childbearing age, and 37 patients remained pregnant during the follow-up of the study. No differences were found in the clinical outcomes among women who had children and who did not. CONCLUSIONS: Cryopreserved allograft is a valid option, especially in complex infective endocarditis and in women of childbearing age. A careful choice of allograft size and implantation technique can reduce the risk of SVD.
引用
- Nappi F, Nenna A, Petitti T, et al. Long-term outcome of cryopreserved allograft for aortic valve replacement. J Thorac Cardiovasc Surg. 2018. PMID: 29759737. doi:10.1016/j.jtcvs.2018.04.040
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。